The diabetogenic capacity of the M-variant of encephalomyocarditis (EMC) virus was markedly diminished after passage in mouse kidney cell cultures. One passage in mice fully restored this capacity. Virus harvested after five passages in either susceptible (SWR/J) or resistant (C57BL/6J) strains of mice was capable of producing diabetes in susceptible SWR/J mice but not in resistant C57BL/6J mice. Resistance was not overcome by inoculating mice with high concentrations of virus. Immunofluorescence studies showed that islets from strains of mice (i.e. CBA, AKR, C57BL/6J, A/J) that did not develop diabetes after infection with EMC virus, nonetheless, contained virus antigens. The percentage of cells in the islets containing virus antigens varied from 3"6 ~ in CBA to 13"5 ~ in A/J. In contrast, 38 of the islet cells in susceptible SWR/J mice contained virus antigens. It is concluded that both the genetic background of the host and the passage history of the virus influence the development of diabetes.
INTRODUCTION
The M-variant of encephalomyocarditis (EMC) virus attacks the beta cells of the pancreas and produces a diabetes-like syndrome in mice (Craighead & McLane, I968; Craighead, I975; Notkins, 1977) . Only certain strains of mice develop virus-induced diabetes and susceptibility is inherited as an autosomal recessive trait (Boucher et al. I975; Ross et al. 1976 ) . Studies on the replication of the virus indicate that beta cells from strains of mice that develop diabetes are more susceptible to infection than beta cells from strains of mice that do not develop diabetes (Yoon & Notkins, 1976; Yoon et al. 1976) . It is thought that genetically controlled differences in susceptibility at the level of the beta cell determine whether or not the infected host develops diabetes. In addition, the development of diabetes is influenced by the strain of virus employed (Ross et al. I975) .
The present investigation was initiated to determine whether the host in which the virus is passaged and/or the concentration of virus influence the severity of diabetes in susceptible and resistant strains of mice. (Craighead & McLane, I968) were prepared from the hearts of infected mice or passaged by inoculating secondary mouse embryo (SME) cells or mouse kidney cell cultures with a multiplicity of infection of Io (Yoon & Notkins, I976) . The virus was assayed on monolayers and the titre expressed as plaque-forming units (p.f.u.). Density gradient purified virus was prepared by inoculating CAF-I SME cells with virus that had been passaged 20 times in CAF-I SME cells. Approx. 4o h later, when more than 5o ~ of the monolayer showed cytopathology, cells and media were harvested, pooled, centrifuged at Iooo g for 30 min and separated into cell pellet and supernatant fluid. The cell pellet was resuspended in Eagle's minimal essential medium, disrupted by two freeze-thaw cycles, and sonicated at 50 W for 15 to 2o s. The cellular debris was removed by centrifugation at Ioooo g for 3o min and the cellular extract saved. The supernatant fluid, which also contained virus, was clarified by centrifugation at 10ooo g for 30 min and combined with the cellular extract. These materials were centrifuged at I2OOOO g for 2 h and the resulting pellet was resuspended in Dulbecco's phosphate buffered saline (PBS, pH 7"3). The resuspended virus was sedimented through 35 ~ sucrose solution at 45ooo rev/min for I5o min in a Spinco SW 5o. I rotor. The pellet was resuspended in PBS and then further purified by density gradient centrifugation in a pre-formed linear 15 to 50 CsCI gradient at 4oooo rev/min for 8 h in a Spinco SW 5o. 2 rotor. The visible band at a density of I'33 to 1-34 g/ml was collected and then dialysed against PBS. The titre of this tissue culture-passaged, density-gradient purified virus was 7"2 × IO 9 p.f.u./ml after dialysis.
METHODS

Preparation of virus. Stock pools of the M-variant of EMC virus
Preparation of labelled antibody. Antibody to EMC virus was prepared by repeated intraperitoneal inoculation of NIH Swiss male mice with 2o 5 p.f.u, of virus at 7-to 2o-day intervals. After the 6th inoculation, serum was obtained and y-globulin was purified by ammonium sulphate precipitation followed by DEAE cellulose column chromatography. The y-globulin fraction was labelled with fluorescein isothiocyanate (FITC, Kawammura, 2969) . The labelled y-globulin was then adsorbed with acetone-treated mouse liver powder to eliminate non-specific fluorescence. The specificity of labelled antibody was established by inhibition tests using unlabeUed anti-EMC sera. Cryostat sections (5 #m in thickness) of pancreas from infected animals were fixed in cold acetone for 5 min at room temperature, flooded with FITC-labelled anti-EMC antibody and incubated at 37 °C for 3o min. Sections from uninfected animals served as controls. Sections were then observed with a Zeiss fluorescence microscope using a UG-I excitation filter system. Animals. Swiss NIH mice were obtained from the breeding colony at the National Institutes of Health. Other mice were purchased from Jackson Laboratory (Bar Harbour, ME) and all animals were maintained on Purina-NIH mouse ration containing 5"0 ~ fat and 2"3 ~ protein. Only male mice were used and at the time of infection the animals were 6 to 22 weeks old. Unless otherwise indicated, mice were inoculated intraperitoneally with stock virus prepared from mouse hearts (CAF-I ; Yoon & Notkins, r976 ) .
Glucose assay. Glucose levels were measured in blood from the retro-orbital venous plexus by use of a glucose oxidase assay with O-dianisidine dihydrochloride as the indicator dye. Blood for glucose tolerance tests was obtained 6o min after intraperitoneal injection of 2 mg of glucose per gram weight. Non-fasting (NF) glucose levels were measured 7 and I4 days after infection, and glucose tolerance tests (GTT) were performed IO and 27 days after infection. These four values were then combined to give the glucose index for each mouse: glucose index = (4 × NF day I4) + (3 × NF day 7) +(2×GTT day 27)+(2 ×GTT day Io)+ 2o.
The index was used to eliminate some of the variability associated with individual glucose 
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determinations and weighted to emphasize non-fasting hyperglycaemia and persistence of abnormal glucose levels. The justification for the index is found elsewhere (Ross et al. I976) . In these earlier studies (Ross et al. i976 ) it was shown that the mean glucose index of 230 uninfected male mice was I3o + 22 mg/~oo ml. Based on a 99 ~ one-sided confidence limit, the upper limit of normal for male mice was I8o'5 mg/Ioo ml. Any mouse with a glucose index greater than I8O'5 mg/ml was classified as abnormal. Any mouse with a glucose index greater than 25o mg/Ioo ml, which was approx. 5 standard deviations above the mean, was classified as diabetic. These criteria were used in the present experiments.
RESULTS
Effect of different doses and preparations of virus on induction of diabetes
The effect of different doses of virus on the induction of diabetes in 6-to 8-week-old Swiss NIH male mice is shown in Table I . The highest percentage of animals developing diabetes occurred when mice were inoculated with IO p.f.u, of mouse-passaged (CAF-0 virus. At I& p.f.u, there was a substantial reduction in the number of animals developing diabetes. In contrast, mice inoculated with io 2 to xo 4 p.f.u, of tissue culture-passaged, densitygradient purified virus (CAF-I) developed only minimal evidence of diabetes. However, at a concentration of Io 6 p.f.u., a substantial percentage of the animals developed diabetes. Thus, while only a high concentration of tissue culture-purified virus was capable of producing diabetes, the same concentration of mouse-passaged material resulted in a marked reduction in the percentage of animals developing diabetes.
Effect of virus passage on induction of diabetes
Evidence that the diabetogenic properties of tissue culture-passaged, density-gradient purified virus (CAF-I) could be restored by passage through animals is illustrated in Table 2 . After one passage of tissue culture-purified virus through Swiss NIH mice, the virus harvested from hearts was capable of producing diabetes in 67 ~ of inoculated animals. Additional passages through mice did not increase the diabetogenic properties of the virus.
Induction of diabetes by virus passaged in kidney cell cultures from susceptible and
resistant strains of mice The capacity of virus passaged five times in primary mouse kidney cell cultures from susceptible (SWR]J) and resistant (C57BL/6J) strains of mice to produce diabetes is illustrated in Table 3 . Virus pools prepared from either SWR/J or C57BL[6J kidney cell cultures were capable of producing a low incidence of diabetes when injected into susceptible SWR]J mice. The same virus pools failed to produce diabetes when injected into C57BL/6J mice.
Induction of diabetes by virus passaged in susceptible and resistant strains of mice
The data in Table 4 show that virus passaged five times in hearts of either SWR/J or C57BL/6J mice was capable of producing diabetes when injected into susceptible SWR]J mice. In contrast to tissue culture-passaged virus (Table 3) , mouse-passaged virus produced both higher blood glucose levels and a higher incidence of diabetes. Mouse-passaged virus also failed to produce diabetes in C57BL]6J mice.
Virus replication in kidney cell cultures from different inbred strains of mice
The effect of virus passage in kidney cell cultures from different hosts on the capacity of the virus to replicate is illustrated in Table 5 . It can be seen that virus passaged five times in Source of virus* S R/J C57BL/6J CAF-I SWR/J 7"3 x io 7 6. 9 x to 7 6.o x io 7 C57BL/6J 6"3 × IO 7 7"2 x IO 7 6'1 x IO 7 * Virus was passaged five times in SWR/J or C57BL/6J kidney cell cultures. "~ Kidney cell monolayers were inoculated with to-fold dilutions of virus. After I h, methylcellulose was added and2'plaques were counted at 24 h. Titre is expressed in p.f.u./ml. 
Effect of virus dose on the induction of diabetes in resistant mice
Previous studies showed that C57BL/6J, CBA and AKR mice failed to develop diabetes when inoculated with ios p.f.u, of mouse-passaged virus (Boucher et al. I975; Yoon & Notkins, 1976) . To see whether this resistance could be overcome with higher concentrations of virus, I2-week-old mice were inoculated with Io s, IO and Io 6 p.f.u, of mouse-passaged virus. The data in Table 6 show that when susceptible (NIH) mice were inoculated with virus, a high percentage of animals developed abnormal or diabetic glucose indices. The highest incidence of diabetes occurred with IO 4 p.f.u. A marked reduction in the incidence of diabetes occurred with ~o 6 p.f.u., similar to that observed in Table L When resistant CBA mice were inoculated with different concentrations of virus, none of the animals developed diabetes. A small percentage of the animals, not significantly different from uninfected controls, showed abnormal glucose indices. Similarly, none of the AKR or C57BL]6J mice developed diabetes and only 2 ~ of the C57BL]6J mice showed abnormal glucose indices when injected with Io 6 p.f.u. It is concluded that, at least in the three strains of mice tested, resistance is not overcome by inoculation with high concentrations of virus. * Seven-week-old male mice were infected with 5 x io a p.f.u, of mouse-passaged virus (CAF-D and at different times thereafter, sections of the pancreas were stained with FITC-labelled anti-EMC antibody.
Virus antigens in pancreatic islets of susceptible and resistant strains of mice
To see whether there was any relationship between the number of beta cells infected and the development of diabetes, susceptible and resistant strains of mice were infected with mouse-passaged virus (CAF-I) and at different times thereafter, sections of pancreas were stained with FITC-labelled anti-EMC antibody (Hayashi, Boucher & Notkins, I974) . The data in Table 7 show the percentage of islets that became infected increased with time and was maximal on day 3. In the susceptible SWR/J strain, 93 ~ of the islets showed virus antigens at 3 days, while in the resistant strains (CBA, AKR, A/J and C57BL/6J) 59 to 95 of the islets showed virus antigens. The major difference between strains of mice that developed diabetes and strains that did not, was the percentage of cells in each islet that became infected. At 3 days after infection, the percentage of cells containing virus antigens in islets from CBA, AKR, A/J and C57BL/6J was 3"6 ~o, 7"4 ~o, I3"5 ~o and I2 ~o, respectively. In contrast, 38 ~ of cells in islets from the susceptible SWR/J strain contained virus antigens. These studies show that in strains of mice that are resistant to the development of EMCinduced diabetes, considerably fewer islet cells become infected.
DISCUSSION
Previous studies showed that the M-variant of EMC virus produced diabetes in only certain inbred strains of mice (Boucher et al. I975; Craighead, 1975; Ross et al. I976; Yoon & Notkins, 1976; Yoon et al. 1976) . The present experiments demonstrate that both the passage history and concentration of the virus are important determining factors. Virus that had been passaged in mouse kidney cell cultures was considerably less diabetogenic than virus that had been passaged in animals. Up to IO times more of the tissue culture-passaged virus was required to produce diabetes. One passage through animals, however, restored the diabetogenic capacity of the virus. One possible explanation for these findings is that the stock virus pool is made up of two populations of virus; one that has a tropism for beta cells and is diabetogenic and the other that does not have a tropism for beta cells and is non-diabetogenic. Growth of virus in the kidney cell cultures may have favoured replication of the non-diabetogenic strain. In vivo, both beta-tropic and non-beta-tropic strains would have an opportunity to replicate. The recent demonstration that EMC virus (Yoon & Notkins, i976 ) and mumps virus (Prince et al. I977) can replicate in mouse and human beta cell cultures, respectively, suggests that beta cell cultures prepared from susceptible mice might prove more useful than kidney cell cultures in adapting and/or selecting beta-tropic strains of EMC virus. Experiments to test this possibility are in progress.
The observation that virus passaged five times in SWR/J mice produced diabetes in SWR/J but not C57 BL/6J mice and that virus passaged five times in C57BL/6J mice also produced diabetes in SWR/J but not C57BL/6J mice indicates that the development of diabetes in only certain strains of mice is not simply due to virus adaptation to the host. Moreover, the capacity of the virus to replicate in SWR/J or C57BL/6J kidney cells was not altered by passage of the virus in the homologous or heterologous kidney cell cultures. Further experiments showed that resistance to the development of diabetes was not overcome by inoculating resistant strains of mice with up to Io 3 times the amount of virus that produced diabetes in susceptible strains of mice. Why high concentrations of mouse-passaged virus (I o ~ p.f.u.) was somewhat less diabetogenic in susceptible NIH mice than lower concentrations of the same virus (Io ~ to Io 4 p.f.u.) is still not clear. Whether this was due to virus interference (e.g., defective interfering particles, a passenger agent, interferon induction) or some other property of the virus pool remains to be determined.
Earlier studies showed that inbred strains of mice infected with EMC virus could be separated into three clinically distinct groups (Craighead, I975; Notkins, I977) ; those with elevated blood glucose levels and abnormal glucose tolerance tests; those with only abnormal glucose tolerance tests; and those with neither abnormality. In as much as there are more than enough beta cells in the normal pancreas to handle the physiological requirements of the host, moderate to extensive destruction of beta cells would have to occur before clinical symptoms became apparent. The present study, using immunofluorescence, shows that susceptibility of the beta cells to infection varies considerably even among so called 'resistant' strains of mice. Several times more infected cells were found in islets of C57BL/6J and A/J mice than in CBA and AKR mice. The nature of the infected cells in islets of resistant mice has not been unequivocally established, but based on their location in the islets, they appear to be beta cells. If this turns out to be the case, then it remains to be determined why only some beta cells in the islets of resistant mice become infected and others do not. Possibly, there are different subpopulations of beta cells and only certain of these have receptors for the M-variant of EMC virus. The nature of these cells and the reason for the different degrees of susceptibility is under investigation.
